References
- Magrath I, Jain Vand Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol. 1992; 3: 285–295
- Bouffet E, Frappaz R, Pinkerton R. Burkitt's lymphoma: A model for clinical oncology. Eur J Cancer 1991; 27: 504–509
- Hutchison R E, Murphy S B, Fairclough D L. Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Cancer 1989; 64: 23–28
- Burke J S. The histopathologic classification of non-Hodgkin's lymphomas: Ambiguities in Working Formulation and two newly reported categories. Semin Oncol. 1990; 17: 3–10
- Johnston J M, Yu M T, Carroll W L. c-myc hypermutation is ongoing in endemic, but not all Burkitt's lymphoma. Blood 1991; 78: 2419–2425
- Shiramizu B, Barriga F, Neequaye J. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma. Relevance to geography and Epstein-Barr virus association. Blood. 1991; 77: 1516–1526
- Shiramizu B, Magrath I. Localization of break points by polymerase chain reactions in Burkitt's lymphoma. Blood. 1990; 75: 1848–1852
- Berard C, O'Conor G T, Thomas L B. Histopathological definition of Burkitt's tumor. Bull World Health Organ. 1969; 40: 601–607
- Magrath I. African Burkitt's lymphoma: History, biology, clinical features and treatment. Am J Pediatr Hematol Oncol. 1991; 13: 222–246
- Bramswig J H, Wegele M, Lengerke H JV. The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemia. Acta Pediatr Scand. 1989; 78: 296–230
- Tanner J M, Whitehouse R M, Takaishi M. Standards from birth to maturity for height, weight, and height velocity. Arch Dis Child. 1966; 41: 613–635
- Ziegler J H. Treatment of 54 American patients with Burkitt's lymphoma is similar to the African experience. N Engl J Med. 1977; 297: 75–80
- Al-Attar A, Al-Mondhiry H, Al-Bahrani Z. Burkitt's lymphoma in Iraq; Clinical and pathologic study of 47 patients. Int J Cancer 1979; 23: 14–17
- Peto R, Pike M C, Armitage P. Design and analysis of randomised clinical trials requiring prolonged observation of each patients. Br J Cancer 1977; 35: 1–39
- Murphy S B, Bowman W P, Abromowitch M. Results of treatment of advanced-stage Burkitt's lymphoma and B cell(Slg +) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986; 4: 1732–1739
- Çavdar A O, Yavuz G, Babacan E. Burkitt's lymphoma in Turkish children: Clinical, viral (EBV) and molecular studies. Leuk Lymphoma. 1994; 14: 323–330
- Kutluk T, Sanalioĝlu F, Gogtis S. Burkitt's lymphoma in Turkish children: A retrospective analysis of 104 cases. Turk J Cancer 1993; 23: 81–88
- Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res. 1990; 55: 133–270
- Yih W Y, Myers S L, Meshul C K. African Burkitt's lymphoma: Case report and light and electron microscopic findings. Oral Surg Oral Med Oral Pathol. 1990; 70: 760–764
- DeThe G, Gaser A, Day N E. Epidemiological evidence for a causal relationship between Epsten-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978; 274: 756–761
- Durbin W A, Sullivan J L. Epstein-Barr virus infection. Pediatr Rev. 1994; 15: 63–68
- Katz B Z, Raab-Traub N, Miller G. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative disease. J Infect Dis. 1989; 160: 589–598
- Çavdar A O, Gözdasoglu S, Yavuz G. Burkitt's lymphoma between African and American types in Turkish children: Clinical, viral (EBV) and molecular studies. Med Pediatr Oncol. 1993; 21: 36–42
- Magrath I, Lee Y J, Anderson T. Prognostic factors in Burkitt's lymphoma importance of total tumor burden. Cancer 1980; 45: 1507–1515
- Schwenn R, Blattner R, Lynch E. HiC-COM: A 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol. 1991; 9: 133–138